Search research articles
Contact Us
Filters
Showing results (101-110 of 119) with videos related to
Page
of 12
Sort By:
Communications Biology
|
April 10, 2021
Genomic landscape of extraordinary responses in metastatic breast cancer
Sun Min Lim, Eunyoung Kim, Kyung Hae Jung, et al.
British Journal of Cancer
|
June 24, 2020
Correction: Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response
Min Hwan Kim, Jae-Hwan Kim, Ji Min Lee, et al.
Scientific Reports
|
June 19, 2023
Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer
Kyoungmin Lee, Jongwon Lee, Jungmin Choi, et al.
Cancer Science
|
July 9, 2024
Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2-positive metastatic breast cancer
Hiroji Iwata, Binghe Xu, Sung-Bae Kim, et al.
Cancer Immunology, Immunotherapy : CII
|
August 6, 2024
Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer
Changhee Park, Koung Jin Suh, Se Hyun Kim, et al.
Journal of the National Cancer Institute
|
May 11, 2023
Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer
Min Hwan Kim, Gun Min Kim, Jin Mo Ahn, et al.
Genome Biology
|
April 14, 2026
Proteogenomic decoding of chemotherapy resistance in patients with triple-negative breast cancer
Dong Ki Lee, Min Hwan Kim, Yumi Hwang, et al.
Clinical and Molecular Hepatology
|
December 28, 2025
Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer
Daeseong Kim, Nam Suk Sim, Seonjeong Woo, et al.
EMBO Molecular Medicine
|
October 22, 2019
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer
Mi Ran Yun, Hun Mi Choi, You Won Lee, et al.
The New England Journal of Medicine
|
March 23, 2022
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
Javier Cortés, Sung-Bae Kim, Wei-Pang Chung, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 119) with videos related to
Sort By:
Page
of 12
Communications Biology
|
April 10, 2021
Genomic landscape of extraordinary responses in metastatic breast cancer
Sun Min Lim, Eunyoung Kim, Kyung Hae Jung, et al.
British Journal of Cancer
|
June 24, 2020
Correction: Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response
Min Hwan Kim, Jae-Hwan Kim, Ji Min Lee, et al.
Scientific Reports
|
June 19, 2023
Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer
Kyoungmin Lee, Jongwon Lee, Jungmin Choi, et al.
Cancer Science
|
July 9, 2024
Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2-positive metastatic breast cancer
Hiroji Iwata, Binghe Xu, Sung-Bae Kim, et al.
Cancer Immunology, Immunotherapy : CII
|
August 6, 2024
Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer
Changhee Park, Koung Jin Suh, Se Hyun Kim, et al.
Journal of the National Cancer Institute
|
May 11, 2023
Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer
Min Hwan Kim, Gun Min Kim, Jin Mo Ahn, et al.
Genome Biology
|
April 14, 2026
Proteogenomic decoding of chemotherapy resistance in patients with triple-negative breast cancer
Dong Ki Lee, Min Hwan Kim, Yumi Hwang, et al.
Clinical and Molecular Hepatology
|
December 28, 2025
Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer
Daeseong Kim, Nam Suk Sim, Seonjeong Woo, et al.
EMBO Molecular Medicine
|
October 22, 2019
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer
Mi Ran Yun, Hun Mi Choi, You Won Lee, et al.
The New England Journal of Medicine
|
March 23, 2022
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
Javier Cortés, Sung-Bae Kim, Wei-Pang Chung, et al.
Page
of 12